Braxton Turner, MD
Pain Medicine · Gainesville, GANPI 1841271467
Payments from drug & device makers
Across 170 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$884
- Medtronic$630
- Forte Bio-pharma LLC$273
- Boston Scientific$138
- Abbott$118
- Collegium Pharmaceutical, Inc.$102
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,182100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 61 | $884 |
| Medtronic(2 entities) | 15 | $630 |
| Forte Bio-pharma LLC | 9 | $273 |
| Boston Scientific | 8 | $138 |
| Abbott | 5 | $118 |
| Collegium Pharmaceutical, Inc. | 7 | $102 |
| Nevro Corp. | 5 | $97 |
| Sentynl Therapeutics, Inc. | 7 | $92 |
| Daiichi Sankyo Inc. | 6 | $90 |
| GRT US Holding, Inc. | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $61 |
| SPR Therapeutics, Inc | 4 | $53 |
| Biotronik NRO, Inc. | 2 | $48 |
| Biodelivery Sciences International, Inc. | 3 | $39 |
| Amgen | 3 | $39 |
| Valinor Pharma, LLC | 2 | $37 |
| Virtus Pharmaceuticals LLC | 2 | $37 |
| Averitas Pharma Inc. | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Vertex | 1 | $31 |
| Protega Pharmaceutials Inc | 2 | $31 |
| Bioventus LLC | 1 | $26 |
| Saluda Medical Americas, Inc. | 1 | $26 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Masimo Corporation | 1 | $18 |
| Spinal Simplicity, LLC | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Shionogi Inc | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Pfizer | 1 | $16 |
| Merit Medical Systems Inc | 2 | $15 |
| AstraZeneca | 1 | $14 |
| Baudax Bio Inc. | 1 | $12 |
| Radius Health, Inc. | 1 | $11 |
| MML US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$161
- INTELLIS$107
How this compares
$3,182 in reported general payments places this provider in the 55th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,865 | $56,254 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,346 | $35,314 |
| Xtampza ErOxycodone Myristate | 45 | $28,393 |
| RelistorMethylnaltrexone Bromide | 11 | $25,243 |
| OxycontinOxycodone Hcl | 42 | $20,496 |
| MovantikNaloxegol Oxalate | 41 | $20,248 |
| NucyntaTapentadol Hcl | 20 | $15,461 |
| Gabapentin | 698 | $12,702 |
| Fentanyl | 107 | $12,289 |
| Oxycodone Hcl | 457 | $8,936 |
| Morphine Sulfate ErMorphine Sulfate | 268 | $7,318 |
| Pregabalin | 455 | $6,906 |
| LinzessLinaclotide | 12 | $6,016 |
| Morphine Sulfate | 128 | $4,262 |
| Tizanidine Hcl | 378 | $4,155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta | $102 | $43,85465 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $884 | $25,24311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 203 pain medicine providers in Georgia.
Other pain medicine in Gainesville
- Maged HamzaGainesville$50K
- Ankur PatelGainesville$21K
- Margaret RisoGainesville$19K
- John GivogreGainesville$9K
- Stephanie SmithGainesville$6K
- Arnold WeilMarietta$286K
- Jeffrey GrossmanAtlanta$189K
- Vicente GalanStockbridge$95K
- Rutvij ShahColumbus$86K
- Anthony GrassoMarietta$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.